167 related articles for article (PubMed ID: 16874460)
1. CK2 phosphorylation of SAG at Thr10 regulates SAG stability, but not its E3 ligase activity.
He H; Tan M; Pamarthy D; Wang G; Ahmed K; Sun Y
Mol Cell Biochem; 2007 Jan; 295(1-2):179-88. PubMed ID: 16874460
[TBL] [Abstract][Full Text] [Related]
2. SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.
Tan M; Gallegos JR; Gu Q; Huang Y; Li J; Jin Y; Lu H; Sun Y
Neoplasia; 2006 Dec; 8(12):1042-54. PubMed ID: 17217622
[TBL] [Abstract][Full Text] [Related]
3. SAG/RBX2 is a novel substrate of NEDD4-1 E3 ubiquitin ligase and mediates NEDD4-1 induced chemosensitization.
Zhou W; Xu J; Zhao Y; Sun Y
Oncotarget; 2014 Aug; 5(16):6746-55. PubMed ID: 25216516
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription.
Ampofo E; Kietzmann T; Zimmer A; Jakupovic M; Montenarh M; Götz C
Int J Biochem Cell Biol; 2010 Oct; 42(10):1729-35. PubMed ID: 20637892
[TBL] [Abstract][Full Text] [Related]
5. Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF
Lee A; Rayner SL; De Luca A; Gwee SSL; Morsch M; Sundaramoorthy V; Shahheydari H; Ragagnin A; Shi B; Yang S; Williams KL; Don EK; Walker AK; Zhang KY; Yerbury JJ; Cole NJ; Atkin JD; Blair IP; Molloy MP; Chung RS
Open Biol; 2017 Oct; 7(10):. PubMed ID: 29021214
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of SAG E3 ubiquitin ligase blocks embryonic stem cell differentiation and sensitizes leukemia cells to retinoid acid.
Tan M; Li Y; Yang R; Xi N; Sun Y
PLoS One; 2011; 6(11):e27726. PubMed ID: 22110742
[TBL] [Abstract][Full Text] [Related]
7. Alpha B-Crystallin Protects Rat Articular Chondrocytes against Casein Kinase II Inhibition-Induced Apoptosis.
Lee SW; Rho JH; Lee SY; Yoo SH; Kim HY; Chung WT; Yoo YH
PLoS One; 2016; 11(11):e0166450. PubMed ID: 27851782
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase CK2 activation is required for transforming growth factor β-induced epithelial-mesenchymal transition.
Kim S; Ham S; Yang K; Kim K
Mol Oncol; 2018 Oct; 12(10):1811-1826. PubMed ID: 30171795
[TBL] [Abstract][Full Text] [Related]
9. Coat Protein Regulation by CK2, CPIP, HSP70, and CHIP Is Required for Potato Virus A Replication and Coat Protein Accumulation.
Lõhmus A; Hafrén A; Mäkinen K
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852853
[TBL] [Abstract][Full Text] [Related]
10. Evaluating CK2 activity with the antibody specific for the CK2-phosphorylated form of a kinase-targeting cochaperone Cdc37.
Miyata Y; Nishida E
Mol Cell Biochem; 2008 Sep; 316(1-2):127-34. PubMed ID: 18566753
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2.
Allende-Vega N; Dias S; Milne D; Meek D
Mol Cell Biochem; 2005 Jun; 274(1-2):85-90. PubMed ID: 16335531
[TBL] [Abstract][Full Text] [Related]
13. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.
Gu Q; Tan M; Sun Y
Cancer Res; 2007 Apr; 67(8):3616-25. PubMed ID: 17440073
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells.
Apopa PL; He X; Ma Q
J Biochem Mol Toxicol; 2008 Feb; 22(1):63-76. PubMed ID: 18273910
[TBL] [Abstract][Full Text] [Related]
15. Induced expression of nucleolin phosphorylation-deficient mutant confers dominant-negative effect on cell proliferation.
Xiao S; Caglar E; Maldonado P; Das D; Nadeem Z; Chi A; Trinité B; Li X; Saxena A
PLoS One; 2014; 9(10):e109858. PubMed ID: 25313645
[TBL] [Abstract][Full Text] [Related]
16. SAG/ROC2/Rbx2/Hrt2, a component of SCF E3 ubiquitin ligase: genomic structure, a splicing variant, and two family pseudogenes.
Swaroop M; Gosink M; Sun Y
DNA Cell Biol; 2001 Jul; 20(7):425-34. PubMed ID: 11506706
[TBL] [Abstract][Full Text] [Related]
17. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
18. CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Choi S; Baldini C; Konstantinidou G; Pandolfi PP
Mol Cell Biochem; 2008 Sep; 316(1-2):149-54. PubMed ID: 18566754
[TBL] [Abstract][Full Text] [Related]
19. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
Im E; Chung KC
J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
[TBL] [Abstract][Full Text] [Related]
20. Annexin-1 Mediates Microglial Activation and Migration via the CK2 Pathway during Oxygen-Glucose Deprivation/Reperfusion.
Liu S; Gao Y; Yu X; Zhao B; Liu L; Zhao Y; Luo Z; Shi J
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
